Naltrexone EP Impurity D
Em Estoque
Naltrexone EP Impurity D
Cat. No. ANTPRD860CAS 607732-61-6Em EstoqueSintetizado
Dados Técnicos
Cat. No.ANTPRD860
CAS607732-61-6
Fórmula Mol.C40H44N2O8
Peso Mol.680.798 g/mol
IUPAC(4R,4aS,7aR,12bS)-10-[(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-7-oxo-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-10-yl]-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
SMILESO=C1CC[C@@]2(O)[C@H]3Cc4cc(-c5cc6c7c(c5O)O[C@H]5C(=O)CC[C@@]8(O)[C@@H](C6)N(CC6CC6)CC[C@]758)c(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5
InChIInChI=1S/C40H44N2O8/c43-25-5-7-39(47)27-15-21-13-23(31(45)33-29(21)37(39,35(25)49-33)9-11-41(27)17-19-1-2-19)24-14-22-16-28-40(48)8-6-26(44)36-38(40,30(22)34(50-36)32(24)46)10-12-42(28)18-20-3-4-20/h13-14,19-20,27-28,35-36,45-48H,1-12,15-18H2/t27-,28-,35+,36+,37+,38+,39-,40-/m1/s1
Chave InChINGSAYZAPVYNVHK-YAUKWVCOSA-N
Descrição
Visão geral
Naltrexone EP Impurity D, 607732-61-6, (4R,4aS,7aR,12bS)-10-[(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-7-oxo-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-10-yl]-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one
A Anant Labs é a renomada e autêntica fabricante e fornecedora de Naltrexone EP Impurity D na Índia.
A Anant tem expertise em química orgânica sintética e análise farmacêutica e fornece serviços de pesquisa personalizados com custo acessível e precisão para a indústria.
Sinônimos
2,2'-Bisnaltrexone(2,2'-Bimorphinan)-6,6'-dione, 17,17'-bis(cyclopropylmethyl)-4,5:4',5'-diepoxy-3,3',14,14'-tetrahydroxy-, (5alpha)-(5'alpha)-[2,2'-Bimorphinan]-6,6'-dione, 17,17'-bis(cyclopropylmethyl)-4,5:4',5'-diepoxy-3,3',14,14'-tetrahydroxy-, (5alpha)-(5'alpha)-(2,2'-BIMORPHINAN)-6,6'-DIONE, 17,17'-BIS(CYCLOPROPYLMETHYL)-4,5:4',5'-DIEPOXY-3,3',14,14'-TETRAHYDROXY-, (5.ALPHA.)-(5'.ALPHA.)-Naltrexone EP Impurity D2,2'-Bisnaltrexone (Naltrexone Impurity) (1mg/ml in Acetonitrile)17,17'-Bis(cyclopropylmethyl)-4,5alpha:4',5'alpha-diepoxy3,3',14,14'-tetrahydroxy-2,2'-bimorphinanyl-6,6'-dione; (5alpha)-(5'alpha)-17,17'-Bis(cyclopropylmethyl)-4,5:4',5'-diepoxy-3,3',14,14'-tetrahydroxy-[2,2'-bimorphinan]-6,6'-dione; 2,2'-Bisnaltrexone; Pseudonaltrexone; Naltrexone Impurity(4R,4'R,5S,5'S,9R,9'R,17S,17'S)-3,3'-bis(cyclopropylmethyl)-5,5',12,12'-tetrahydroxy-2,2',3,3',4,4',5,5',6,6',7,7',9,9',18,18'-hexadecahydro-[13,13'-bi(4,12-methanobenzofuro[3,2-e]isoquinoline)]-8,8'(1H,1'H)-dionePseudonaltrexone; (4R,4'R,5S,5'S,9R,9'R,17S,17'S)-3,3'-bis(cyclopropylmethyl)-5,5',12,12'-tetrahydroxy-2,2',3,3',4,4',5,5',6,6',7,7',9,9',18,18'-hexadecahydro-[13,13'-bi(4,12-methanobenzofuro[3,2-e]isoquinoline)]-8,8'(1H,1'H)-dione